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Introduction: Surgically induced, combined volume and pressure overload has been used
in rabbits to create a simplified and reproducible model of acute left ventricular (LV) failure.
Materials and Methods: New Zealand white male rabbits (n=24, mean weight
3.1±0.2 kg) were randomly assigned to either the Control group (n=10) or to the Heart
Failure group (HF, n=14). Animals in the Control group underwent “sham” procedures.
Animals in the HF group underwent procedures to induce LV volume overload by inducing
severe aortic valve regurgitation with aortic cusp disruption and pressure overload using
an occlusive silver clip positioned around the pre-renal abdominal aorta.
Results: Following Procedure-1 (volume overload) echocardiography confirmed severe
aortic regurgitation in all animals in the HF group, with increased mean pulse pressure dif-
ference from 18±3 to 38±3 mmHg (P <0.0001). After Procedure-2 (pressure overload)
all animals in the HF group showed clinical and echocardiographic signs of constriction of
the abdominal aorta and echocardiography confirmed progressively declining LV function.
At the end of the protocol there was a significant increase of the heart/body weight ratio in
the HF group vs. Control group (4.6±0.2 vs. 2.9±0.1 g/kg, P <0.05), and echocardiogra-
phy showed in HF group significant increase of the LV end-diastolic diameter (2.15±0.09
vs. 1.49±0.03 cm, P <0.001) and reduction of the LV shortening fraction (26.3±3.8 vs.
41.3±1.6%, P<0.001).
Conclusion:This experimental model: (a) consistently produces LV hypertrophy/dilatation
and subsequent congestive heart failure, (b) provides new data on the time course of LV
dilatation, hypertrophy and failure, (c) allows study of the progress and evolution of LV sys-
tolic and diastolic dysfunction in the presence of induced LV failure, (d) is suitable to study
intervention or pharmacological administration to reduce the negative effects of acute LV
failure.
Keywords: congestive heart failure, experimental research, left heart failure, ventricular dilatation, ventricular
hyprtrophy
INTRODUCTION
Left ventricular (LV) dilatation and hypertrophy have been created
in experimental animal models by inducing LV volume or pressure
overload.
In the last two decades the induction of experimental aor-
tic valve regurgitation has been used to induce LV volume
overload (1–3).
Several studies have been reported with this experimental
model of volume overload induced by aortic valve regurgitation
to evaluate systolic and diastolic ventricular function, the devel-
opment of myocardial fibrosis and myocyte degeneration, and the
effects of various medications (4–9).
Left ventricular hypertrophy has been studied in other exper-
imental studies on animals after inducing systemic reno-vascular
hypertension by clipping one of the renal arteries (10, 11).
This experimental model of renal hypertension with renal
artery clipping has been used to study variations of biochemi-
cal and humoral factors as well as changes in the aortic wall and
in the myocardium (12–20).
As an alternative method to induce LV hypertrophy, induc-
tion of proximal systemic hypertension has been obtained
by narrowing the abdominal aorta with various technical
procedures (21–26).
This experimental model of proximal systemic hypertension
and subsequent LV hypertrophy has allowed studies on arterial
wall reactivity and remodeling, endothelial nitric oxide produc-
tion, renal function, adrenergic response, myocardial oxidative
stress, and macrophage migration (21–33).
The combination of experimental volume and pressure over-
load of the left ventricle has been less frequently used in previous
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animal models, predominantly to study electrophysiology, and
rhythm disturbances (34–37).
We report the use of a model of surgically induced, combined
volume, and pressure overload in rabbits.
Previous authors described a 2-stage model of heart failure
in the rabbit, with sacrifice of the animals at 6 weeks after the
first operation (34). We have introduced changes in the protocol
extending the observation period to 8 weeks after the operation
and characterizing the model using in particular echocardiography
and micro-CT scanning.
We present our simplified and reproducible model, suitable for
any of the following studies:
(a) myocardial and vascular structure and ultra-structure, metab-
olism and function, during and after the development of left
heart failure;
(b) effects of the combined volume and pressure overload
on the conduction tissues and potential development of
arrhythmias;
(c) potential prevention of myocardial and vascular remodeling
due to combined volume and pressure overload;
(d) treatment of left heart failure with any type and/or combina-
tion of interventions and/or medications.
MATERIALS AND METHODS
EXPERIMENTAL ANIMAL MODEL
New Zealand white male rabbits (n= 24) were arbitrarily assigned
to either the Control group (n= 10) or to the HF group (n= 14).
Animals in the Control group underwent“sham”procedures,while
animals in the HF group underwent the procedures to induce LV
volume overload and pressure overload. The entire protocol is
summarized in Figure 1.
PROCEDURE-1=VOLUME OVERLOAD
All rabbits were anesthetized with ketamine (50 mg/kg) and main-
tained with 2% isofluorane, after tracheal intubation and with
self-ventilation.
Color Doppler echocardiography was performed with a GE
Vivid 3 ultrasound recorder using a 5-MHz transducer in all
animals before the surgical procedure.
Through a longitudinal incision in the right side of the neck,
the right carotid artery was dissected free, distally ligated, and
proximally controlled with a tie (Figure 2).
Through a 1-mm incision on the anterior aspect of the right
carotid artery, a sharp, bevel-tipped 1.22 mm catheter was intro-
duced into the proximal right carotid artery (Figure 3), advanced
retrogradely toward the ascending aorta, and connected to a pres-
sure transducer whose output was monitored and recorded using
ACODAS (Dataq Instruments, Akron, OH, USA) (Figure 4).
CONTROL GROUP
At this point for the animals in the Control group the catheter was
removed from the right carotid artery, the proximal carotid artery
was ligated, the tissues were closed in layers and the “sham” pro-
cedure terminated, with recovery of the animals from the general
anesthesia.
HEART FAILURE GROUP
In the animals in the Heart Failure group aortic valve regurgita-
tion was obtained by disruption of ≥2 aortic leaflets by repeatedly
moving the catheter across the aortic valve into the left ventri-
cle, with continuous pressure recording. Fluoroscopy was not
used. The degree of aortic valve regurgitation obtained was judged
adequate when the on-line monitored pulse pressure (difference
between systolic and diastolic pressure), measured through the
same catheter when positioned in the ascending aorta, increased
between 80 and 100% in comparison with the pre-procedure value.
The maneuver was repeated until the desired degree of aortic valve
regurgitation was reached.
At this point the catheter was withdrawn, the proximal carotid
artery ligated, and the tissues were closed in layers. The animals
were then allowed to recover from the general anesthesia.
Color Doppler echocardiography was performed in all animals
of the Heart Failure group after the surgical procedure to eval-
uate the presence and degree of aortic valve regurgitation, LV
FIGURE 1 | Experimental protocol.
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FIGURE 2 | (A) Through a longitudinal incision in the right side of the neck,
the right carotid artery was dissected free, and (B) distally ligated and
proximally controlled with a tie.
dimensions (end-diastolic diameter), and function (shortening
fraction). Aortic valve regurgitation was defined as severe in the
presence of a jet >65% of the annulus.
At the end of the procedure but before recovery from anes-
thesia the animals were also observed for clinical signs of aortic
valve regurgitation (low diastolic blood pressure, loud early dias-
tolic murmur) and in the following 3 weeks for the appearance of
clinical signs of left heart failure: respiratory distress, tachypnea,
cyanosis, edema, weight loss.
PROCEDURE-2=PRESSURE OVERLOAD
After an interval of 3 weeks,all animals underwent a second general
anesthesia with tracheal intubation as described before.
Color Doppler echocardiography was performed in all animals
before the surgical procedure.
Through a longitudinal laparotomy (Figure 5) the abdominal
aorta and the renal arteries were identified, and the abdominal
aorta was dissected free above the renal arteries.
CONTROL GROUP
At this point for the animals in Control group the “sham” proce-
dure was completed with the closure of the laparotomy incision in
FIGURE 3 |Through a 1-mm incision on the anterior aspect of the right
carotid artery, a sharp, bevel-tipped 1.22 mm catheter was introduced
into the proximal right carotid artery and advanced retrograde toward
the ascending aorta and connected to a pressure transducer, with a
computer system for data recording.
FIGURE 4 |The catheter was then connected to a pressure transducer,
with a computer system for data recording.
layers, and the animals were allowed to recover from the general
anesthesia.
HEART FAILURE GROUP
In the Heart Failure group a pre-measured (2.44 mm) silver
clip was positioned around the pre-renal abdominal aorta and
occluded, inducing severe aortic narrowing with approximately
50% reduction of the aortic diameter (Figure 6). At this point the
surgical procedure was completed with the closure of the laparo-
tomy incision in layers, and these animals too were allowed to
recover from the general anesthesia.
Color Doppler echocardiography was performed in all animals
of the Heart Failure group after the surgical procedure to evaluate
the degree of stenosis created on the abdominal aorta.
At the end of the procedure the animals were observed for clin-
ical signs of abdominal aorta coarctation (increased non-invasive
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diastolic pressure in the upper limbs, discrepancy between upper
and lower limbs pulsatility, systolic murmur) and in the follow-
ing 5 weeks for the appearance or modification of clinical signs of
left heart failure: respiratory distress, tachypnea, cyanosis, edema,
weight loss.
FOLLOW-UP
In addition to the echocardiography evaluation performed before
each procedure in all animals, Control and HF groups, LV size
(end-diastolic diameter), and function (shortening fraction) was
monitored with serial echocardiography performed after each
procedure and at weekly intervals in the HF group. Five weeks
following Procedure-2, after the final echocardiography evalua-
tion, the animals were weighted, and the weight compared with
the initial body weight, terminated by anesthetic overdose and
the hearts were excised, weighed and sent for morphological
study. Some hearts from each group were scanned by micro-
CT with iodine contrast enhancement by the method previously
described (38).
All procedures were carried out under the UK Home Office
regulations (Animals Scientific Procedures, Act 1986).
Student’s t test has been used to compare the results obtained
in the two groups.
FIGURE 5 |Through a longitudinal laparotomy the abdominal aorta as
well as the renal arteries were identified, and the abdominal aorta was
dissected free above the renal arteries.
FIGURE 6 | (A) A pre-measured (2.44 mm) silver clip was positioned around
the pre-renal abdominal aorta and (B) occluded, inducing severe aortic
narrowing with 50% reduction of the aortic diameter.
RESULTS
Following Procedure-1 (volume overload), while no animal in
Control Group presented aortic regurgitation on evaluation by
color Doppler echocardiography, all animals in the HF group
developed severe aortic valve regurgitation confirmed on echocar-
diography by the presence of a broad jet of aortic regurgitation
(nearing the aortic annulus size), with also diastolic flow reversal in
the descending aorta. In the animals of the HF group an increased
mean pulse pressure difference from 18± 3 to 38± 3 mmHg
(P< 0.0001) was recorded.
After Procedure-2 (pressure overload) in all animals in the HF
group there were signs of abdominal aortic constriction: palpable
thrill and audible bruit.
In the HF group one animal was terminated before the end of
the protocol because of severe clinical deterioration, three animals
developed pericardial effusions and three developed ascites.
MORPHOLOGY
The mean heart/body weight ratio was higher in the HF group
than in the Control group (4.6± 0.2 vs. 2.9± 0.1 g/kg, P< 0.05),
notwithstanding a significant increase in the mean body weight
from the beginning of the protocol in both groups, to 3.8 kg
in the HF group (P< 0.05) and 3.7 kg in the Control group
(P< 0.05).
Figure 7 shows representative micro-CT images of an aortic
valve from the control group and from the HF group. The control
valve shows leaflets that contain sufficient tissue for occlusion. The
aortic valve from the HF group shows retraction of leaflet material
toward the annulus and disruption of the leaflet structure 12 weeks
after the catheter intervention.
FUNCTION
Table 1 shows the results of the echocardiographic functional
evaluation of the LV size and function performed at the end of
the protocol, with significant difference (P< 0.0001) between the
Control Group and the HF group.
FIGURE 7 | Micro-CT images of an aortic valve from the control group
(A) and from the HF group (B). The control valve shows leaflets with
sufficient tissue for occlusion. The aortic valve from the HF group shows
retraction of the leaflets toward the annulus with disruption of the leaflets.
Table 1 | Echocardiographic evaluation at the end of the protocol.
LV end-diastolic diameter 1.49±0.03 cm 2.15±0.09 cm P <0.001
LV shortening fraction 41.3±1.6% 26.3±3.8% P <0.001
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The results of the other echocardiography observations, as well
as the results of histology studies on the LV morphology and the
conduction tissue, will be the subject of separate reports.
DISCUSSION
Pressure and/or volume overload in the systemic circulation char-
acterize the pathophysiology of several congenital and acquired
cardiovascular diseases.
The consequences are LV dilatation and/or hypertrophy, with
ventricular remodeling and systolic and/or diastolic dysfunc-
tion due to the structural, metabolic, and functional changes in
the myocardium, as well as systemic arterial remodeling, with
biochemical and humoral derangements affecting the systemic
circulation.
The currently available knowledge of LV failure is derived from
scattered evidence coming from experimental studies reported in
the literature (1–37) as well as from the information provided by
clinical observations (39–43).
There are still unanswered questions concerning the changes
induced by the acute LV failure on the systolic and diastolic ven-
tricular function, on the subsequent interaction between the two,
and particularly on the effects of the time frame on the evolution
and degree of the progress of the ventricular dysfunction.
This experimental model has the advantages of being repro-
ducible, of inducing acute LV volume overload followed at fixed
interval by induction of pressure overload, and is available to study
the time course of LV dilatation, hypertrophy, and acute LV failure.
The documented increase of the mean heart/body weight ratio
higher in the HF group than in the Control group (4.6± 0.2 vs.
2.9± 0.1 g/kg) with significant difference (P< 0.05) confirmed
that the combined volume and pressure overloaded determined
a substantial ventricular hypertrophy and dilatation.
The significant increase of the LV size and the impairment of
the LV function (Table 1) proved the validity of this experimental
method in creating a congestive LV failure.
In addition to the potential capability to increase the knowledge
currently available on acute LV failure, our experimental model,
being reproducible, allows an unlimited series of potential studies
to monitor the evolution of LV failure, with the subsequent systolic
and diastolic dysfunction, as well as the effects of any type of
treatment, from interventional management to pharmacological
administration.
Studies using this experimental model may be potentially
applicable to the pediatric practice in view of the correspondence
in body weight and heart size of the animals with neonates, and
given similarities in the echocardiographic profile in certain types
of heart failure in pediatric patients determined by severe volume
and pressure overload of the left ventricle, such as the presence of
an intra-cardiac left-to-right shunt associated to an obstruction
in the systemic circulation (aortic coarctation with or without
hypoplastic aortic arch).
Of course the realization of this experimental model requires
the facilities and organization of an animal laboratory equipped
with personnel and tools allowing chronic studies, and the finan-
cial and administrative support required by such this type of
investigation.
CONCLUSION
THIS EXPERIMENTAL MODEL
(a) Consistently produces LV hypertrophy/dilatation and subse-
quent LV failure.
(b) Provides new data on time course of LV dilatation, hypertro-
phy, and failure.
(c) Facilitates study of the progress and evolution of LV systolic
and diastolic dysfunction in the presence of induced LV failure.
(d) Is suitable to study any type of intervention or pharmacolog-
ical administration to reduce the negative effects of acute LV
failure.
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